12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. Heart Test Laboratories (HSCS) saw a notable increase of 41.6%, while Sharps Technology (STSS) experienced a significant drop of 13.4%. Other gainers included MyMD Pharmaceuticals (MYMD), Asensus Surgical (ASXC), Journey Medical (DERM), Lucy Scientific Discovery (LSDI), and Ampio Pharmaceuticals (AMPE). On the losing side, Ainos (AIMD), Dermata Therapeutics (DRMA), Assertio Holdings (ASRT), CareMax (CMAX), and Synaptogenix (SNPX) saw declines in their stock prices.
January 05, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ainos' stock declined by 8.03% to $2.52, with a market cap of $11.7 million.
The decline in stock price could reflect negative market sentiment or reactions to news, possibly leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Assertio Holdings' stock declined by 5.69% to $0.96, with a market cap of $91.0 million.
The negative price movement could suggest a bearish outlook, potentially leading to more short-term selling pressure.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
CareMax's stock declined by 5.38% to $0.38, with a market cap of $42.6 million.
The decline may reflect negative sentiment, which could lead to further short-term price drops.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Dermata Therapeutics' stock fell by 6.48% to $0.64, with a market cap of $2.2 million.
The drop in price may indicate investor concerns or negative news, which could lead to further short-term downside.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Synaptogenix's shares declined by 5.19% to $0.25, with a market cap of $4.9 million.
The decrease in stock price could be due to negative market reactions, possibly indicating more short-term downside.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Sharps Technology's stock fell by 13.4% to $0.39, with a market cap of $5.9 million.
The notable decline suggests negative sentiment or reactions to company-specific news, potentially leading to further short-term downside.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Ampio Pharmaceuticals' stock increased by 5.61% to $1.88, with a market cap of $1.5 million.
The increase in stock price may suggest positive investor sentiment, which could lead to further short-term increases.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
Asensus Surgical's stock increased by 9.37% to $0.35, with a market cap of $92.5 million.
The positive movement in stock price could indicate investor optimism, possibly leading to more short-term increases.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Journey Medical's shares increased by 6.58% to $5.34, with a market cap of $98.8 million.
The uptick in price may suggest growing investor interest, which could lead to short-term positive momentum.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Heart Test Laboratories' stock surged by 41.6% to $0.23, with a market cap of $14.8 million.
The significant surge in price indicates strong investor interest, which could lead to continued short-term momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Lucy Scientific Discovery's stock rose by 5.71% to $0.21, with a market cap of $3.7 million.
The rise in stock price could be a sign of investor confidence, potentially leading to more short-term gains.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70
POSITIVE IMPACT
MyMD Pharmaceuticals' shares rose by 9.52% to $0.23, with a market cap of $11.7 million.
The increase in stock price may attract more attention, potentially leading to further short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90